We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Optimization of CTCA Protocols Offers Significant Radiation Dose Reduction

By HospiMedica International staff writers
Posted on 02 Jun 2010
Optimization of protocols during computed tomography coronary angiography (CTCA) using prospective electrocardiogram (ECG) gating and breast shields can reduce the radiation dose delivered to the female breast by more than 80%.

CTCA is a common, noninvasive procedure that is used to evaluate the coronary arteries. More...
Prospective ECG gating is an imaging technique that allows radiologists to scan only during a certain phase of the heart beat cycle. Breast shields are placed over the chest during a CT exam to block out primary X-ray beams, which are responsible for most of the breast radiation during a CT study.

"As cardiac CTCA has significant potential for the noninvasive imaging of coronary artery disease, its utilization is continuously increased, particularly among young women,” said Sobhi Abadi, M.D., lead author of the study. "Therefore, the radiation dose delivered to the female's breasts should be addressed.”

Researchers from the University Health Network (Toronto, Canada), scanned an adult female phantom using eight different CTCA protocols. "The highest breast dose (82.9 mGy) was associated with using retrospective ECG gating. The lowest breast dose (15.2 mGy) was achieved with prospective gating with narrow exposure window, resulting in an 82% reduction in breast dose. The use of surface breast shields resulted in an additional 38% reduction in breast dose,” said Dr. Abadi.

The study was presented May 4, 2010, at the American Roentgen Ray Society (ARRS) 2010 annual meeting held in San Diego, CA,USA. "All use of ionizing radiation requires constant vigilance to ensure appropriate utilization and this is certainly true for CTCA,” Dr. Abadi concluded. "Significant reductions in radiation dose will reduce the statistical likelihood of causing genetic damage and long-term risk of adverse results.”

Related Links:

University Health Network




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.